Oct 02, 2024
Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers
To take advantage of these opportunities, manufacturers must focus on three key success factors.
Kelly Ke
Aug 28, 2024
Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China
Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
Jul 10, 2024
5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment
In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
Jul 03, 2024
NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items
In China, both public and private not-for-profit hospitals are required to adhere to the Medical Service Pricing Catalogs
Jun 26, 2024
China Aims to Establish a High-Quality All-Inclusive Commercial Health Insurance System in Five Years
City Commercial Health Insurance ("Huiminbao") has been rapidly advancing, focusing on protecting the entire population against major illnesses,
Jun 19, 2024
Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China
Shanghai utilizes value-based pricing negotiations and performance-linked payments for medical consumable reimbursements, providing insights into the future direction of high-value medical consumable reimbursement under China's basic medical insurance.
Jun 12, 2024
China's Commercial Health Insurance Formulary Development: Current State and Future Directions
The commercial health insurance sector in China presents substantial opportunities for growth, with the development of commercial insurance formularies acting
Jun 05, 2024
Accessing Innovative Orphan Therapies in China: Local Advancements
These local initiatives have developed unique early access programs and multi-level funding models for orphan therapies, addressing the core issue of covering high-cost rare disease drugs not included in the national catalog.
May 29, 2024
Fostering Medical Innovation: How China's Social and Commercial Insurance Can Work Together
A healthy innovation ecosystem for medicines in China requires effective integration between basic and commercial health insurance. Success hinges on stakeholders operating within China's social security framework and focusing first on tackling the low-hanging fruit.
May 22, 2024
Impacts of Provincial Central Pooling of Basic Medical Insurance on China's Healthcare Ecosystem
Increasing the risk pooling level is essential for reducing regional disparities and improving the efficiency of BMI funds. This change will deeply affect the supply and demand sides of China's healthcare ecosystem.